IRVINE, Calif., Jan. 21 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), today announced that the corporate overview presented by Executive Chairman, Paul J. McCormick on January 12, 2010 at the OneMedForum is now available on its website. Interested investors may view the video and the accompanying slides by going to the Company's website (http://www.cardiogenesis.com/) and clicking on the Investors link and then OneMedForum Webcast. About Cardiogenesis Corporation Cardiogenesis is a medical device company specializing in the therapies for the treatment of chronic cardiac ischemia. The company's market leading Holmium:YAG laser system and disposable fiber-optic accessories are used to perform a FDA-cleared surgical procedure known as Transmyocardial Revascularization (TMR) to treat patients suffering from angina. Surgical products and accessories for the Cardiogenesis TMR procedure, which are marketed in the U.S. and around the world, have been shown to reduce angina and improve the quality of life in patients with coronary artery disease. For more information on the company and its products, please visit the Cardiogenesis company website at http://www.cardiogenesis.com/ or the direct to patient website at http://www.heartofnewlife.com/. DATASOURCE: Cardiogenesis Corporation CONTACT: Paul McCormick, Executive Chairman of Cardiogenesis Corporation, +1-949-420-1808 Web Site: http://www.cardiogenesis.com/ http://www.heartofnewlife.com/

Copyright